Roivant Sciences Return on Net Operating Assets Analysis

Roivant Sciences Ltd. (ROIV)

26.51 -0.24 (-0.90%) USD | NASDAQ | Feb 13, 10:47

View Return on Net Operating Assets for ROIV.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

Immunovant, Inc.	Upgrade
GSK Plc	Upgrade
Kiniksa Pharmaceuticals International Plc	Upgrade
Silence Therapeutics Plc	Upgrade
Adaptimmune Therapeutics Plc	Upgrade

Return on Equity	Upgrade
Return on Assets	Upgrade
Return on Invested Capital	Upgrade
Profit Margin (Quarterly)	Upgrade
Gross Profit Margin (Quarterly)	Upgrade
Operating Margin (Quarterly)	Upgrade